Institutional Ownership
Onkure Therapeutics Inc
CUSIP 68277Q105COM CL AOKURQ1 2026
13D / 13G Filings
29
Schedule 13D/13G on record
Beneficial Filers
19
Distinct reporting persons
Largest Stake
22.1%
Max % of class reported
Institutional Holders
47
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
29 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Adar1 Capital Management, LLC | 13G | 13.0% | 1.01M | SEC |
| 2 | Feb 17, 2026 | Citadel Advisors LLC | 13G/A | 1.7% | 223.1K | SEC |
| 3 | Feb 17, 2026 | Highbridge Capital Management, LLC | 13G/A | 4.2% | 542.4K | SEC |
| 4 | Jan 30, 2026 | The Vanguard Group | 13G/A | 4.9% | 626.6K | SEC |
| 5 | Nov 28, 2025 | Prosight Management, LP | 13G | 11.0% | 745.6K | SEC |
| 6 | Aug 14, 2025 | Samsara Biocapital, L.P. | 13G/A | — | 913.30M | SEC |
| 7 | Aug 14, 2025 | Cantor Fitzgerald Securities | 13G | 11.0% | 669.5K | SEC |
| 8 | Aug 14, 2025 | Perceptive Advisors LLC | 13G/A | — | 591.1K | SEC |
| 9 | Aug 14, 2025 | Highbridge Capital Management, LLC | 13G | 5.2% | 663.6K | SEC |
| 10 | May 30, 2025 | Acorn Bioventures, L.P. | 13D/A | 22.1% | — | SEC |
19 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Onkure Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Ra Capital Management, L.P. | 4.00M | $16.55M |
| 2 | Acorn Capital Advisors, LLC | 2.84M | $11.76M |
| 3 | Stepstone Group LP | 2.66M | $11.01M |
| 4 | Adar1 Capital Management, LLC | 2.43M | $10.08M |
| 5 | Prosight Management, LP | 2.15M | $8.92M |
| 6 | Bvf Inc/Il | 1.98M | $8.19M |
| 7 | Vivo Capital, LLC | 1.93M | $7.98M |
| 8 | Vestal Point Capital, LP | 1.84M | $7.62M |
| 9 | Foresite Capital Management Vi LLC | 1.45M | $5.99M |
| 10 | Adage Capital Partners Gp, L.L.C. | 1.20M | $4.99M |